BioSpace News Archive

Business

Natera Awarded National MRD Testing Contract by the U.S. Department of Veterans Affairs

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) testing, today announced that it was awarded a nationwide contract, effective Sept. 15, 2022, with the U.S. Department of Veterans Affairs (VA) National Precision Oncology Program.

November 2, 2022
·
4 min read
Biotech Beach

Evolus to Participate in November Conferences

Evolus, Inc. today announced that members of its management team will be participating in two investment conferences in November.

November 2, 2022
·
1 min read
Pharm Country

Panavance Therapeutics to Present at BioFuture 2022

Panavance Therapeutics Inc. (“Panavance” or the “Company”) today announced that Greg Bosch, Chairman and CEO of Panavance Therapeutics will present on Tuesday, November 8, 2022 at 12:00 PM ET at BioFuture 2022 being held in New York, NY.

November 2, 2022
·
3 min read
Bio NC

BPL Supports the Immune Deficiency Foundation Research Grant Program for Second Year in a Row

Bio Products Laboratory, a leading manufacturer of plasma-derived protein therapies with US Offices in Durham, NC, announced its support of the Immune Deficiency Foundation Research Grant Program for the second year in a row.

November 2, 2022
·
3 min read
Job Trends

Bayer to Highlight Additional Analyses From Comprehensive KERENDIA® (finerenone) Clinical Trial Program at the American Society of Nephrology’s 2022 Kidney Week

Bayer will present data from the comprehensive KERENDIA® (finerenone) clinical trial program, conducted in patients with chronic kidney disease (CKD) associated with type 2 diabetes (T2D), at the American Society of Nephrology’s (ASN) Kidney Week 2022, scientific sessions and exchange, from November 3-6.

November 2, 2022
·
18 min read
Policy

Cerus Corporation Announces Award of U.S. Department of Defense Funding for Development of Pathogen Reduced, Lyophilized Cryoprecipitate

Cerus Corporation announced that it has been awarded a $9.1 million contract by the U.S. Department of Defense Industrial Base Analysis and Sustainment program for the development of pathogen reduced, lyophilized cryoprecipitate to treat bleeding due to trauma.

November 2, 2022
·
3 min read
BioForest

The Access to Advanced Health Institute Develops Longer Lasting and Broadly Protective SARS-CoV-2 RNA Vaccine Candidate that is Stable at Room Temperature

The Access to Advanced Health Institute announced results from a study of their new RNA vaccine against COVID-19.

November 2, 2022
·
4 min read
Business

Eton Pharmaceuticals to Report Third Quarter 2022 Financial Results on Thursday, November 10, 2022

Eton Pharmaceuticals, Inc. (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it will report third quarter 2022 financial results on Thursday, November 10, 2022.

November 2, 2022
·
1 min read
Business

Intelligent Bio Solutions Inc. to Present First Quarter 2023 Financial Results and Recent Corporate Update on November 9

Intelligent Bio Solutions Inc. announced that it will release its financial results for the first quarter ended September 30, 2022, shortly after the NASDAQ market close on Wednesday, November 9.

November 2, 2022
·
2 min read
Business

Societal CDMO to Report Financial Results for Third Quarter 2022 on November 9, 2022

Societal CDMO, Inc. announced that the company will release financial results for the third quarter 2022 after the market close on Wednesday, November 9, 2022.

November 2, 2022
·
2 min read